MAPK8 and gastric cancer: Such modulatory effects of JNK on responses to chemotherapies and targeted therapies were also observed in gastric cancer [86], hepatocellular carcinoma [87], head and neck cancer [88], endometrial cancer [89], and ovarian cancer [90].